Zentalis Pharmaceuticals, Inc. (ZNTL)

Zentalis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	41.93	33.9	28.04	43.07	59.71	54.95
Short-Term Investments	290.52	337.18	454.88	394.3	280.17	283.55
Cash & Short-Term Investments	332.45	371.08	482.92	437.37	339.89	338.51
Cash Growth	-32.01%	-23.16%	10.41%	28.68%	0.41%	403.38%
Accounts Receivable	-	5	-	-	-	-
Other Receivables	-	-	-	-	-	0.42
Receivables	-	5	-	-	-	0.42
Prepaid Expenses	10.43	9.98	13.8	14.56	10.64	6.18
Restricted Cash	-	-	-	-	0.24	-
Total Current Assets	342.88	386.07	496.72	451.93	350.77	345.1
Property, Plant & Equipment	35.17	37.23	41.74	50.08	52.84	3.62
Long-Term Investments	-	-	-	21.21	37.5	-
Goodwill	-	-	3.74	3.74	3.74	3.74
Other Intangible Assets	-	-	-	-	-	8.8
Other Long-Term Assets	5.97	7.04	9.5	12.35	9.67	4.3
Total Assets	384.02	430.34	551.69	539.31	454.51	365.56
Accounts Payable	7.77	7.44	14.93	11.25	11.59	8.66
Accrued Expenses	38.15	42.22	51.54	42.85	29.93	18.63
Current Portion of Leases	3.51	3.07	2.62	2.16	1.45	0.9
Current Income Taxes Payable	-	-	0.28	0.38	0.97	0.41
Total Current Liabilities	49.43	52.73	69.37	56.65	43.94	28.6
Long-Term Leases	38.65	39.58	43.15	45.17	44.46	1.1
Long-Term Deferred Tax Liabilities	-	-	-	0.85	1.62	2.48
Other Long-Term Liabilities	0.56	0.85	1.78	2.62	-	-
Total Liabilities	88.64	93.15	114.3	105.29	90.03	32.18
Common Stock	0.07	0.07	0.07	0.06	0.05	0.04
Additional Paid-In Capital	1,398	1,391	1,324	1,031	723.59	509.34
Retained Earnings	-1,103	-1,054	-888.56	-596.37	-359.56	-200.83
Comprehensive Income & Other	0.36	0.56	2.19	-1.35	-0.13	0.04
Total Common Equity	295.38	337.19	437.28	433.8	363.95	308.58
Minority Interest	-	-	0.11	0.22	0.53	24.8
Shareholders' Equity	295.38	337.19	437.39	434.02	364.48	333.38
Total Liabilities & Equity	384.02	430.34	551.69	539.31	454.51	365.56
Total Debt	42.16	42.65	45.77	47.33	45.91	2
Net Cash (Debt)	290.29	328.44	437.15	390.04	293.98	336.51
Net Cash Growth	-34.56%	-24.87%	12.08%	32.68%	-12.64%	406.29%
Net Cash Per Share	4.07	4.62	6.68	7.38	6.89	11.97
Filing Date Shares Outstanding	71.95	71.81	70.96	59.42	45.56	41.04
Total Common Shares Outstanding	71.95	71.28	70.77	59.28	45.49	41.04
Working Capital	293.45	333.34	427.35	395.29	306.83	316.5
Book Value Per Share	4.11	4.73	6.18	7.32	8.00	7.52
Tangible Book Value	295.38	337.19	433.55	430.07	360.22	296.05
Tangible Book Value Per Share	4.11	4.73	6.13	7.25	7.92	7.21
Machinery	1.42	4.81	4.56	4.84	4.39	0.95
Construction In Progress	-	-	0.17	0.04	0.03	0.35
Leasehold Improvements	4.17	4.17	4.24	4.89	4.52	0.05

Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q